Potential for cellular stress response to hepatic factor VIII expression from AAV vector
Hemophilia A and B are coagulation disorders resulting from the loss of functional coagulation factor VIII (FVIII) or factor IX proteins, respectively. Gene therapy for hemophilia with adeno-associated virus vectors has shown efficacy in hemophilia B patients. Although hemophilia A patients are more...
Main Authors: | Irene Zolotukhin, David M Markusic, Brett Palaschak, Brad E Hoffman, Meera A Srikanthan, Roland W Herzog |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116301917 |
Similar Items
-
Thorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations
by: Junping Zhang, et al.
Published: (2024-03-01) -
Single-dose AAV vector gene immunotherapy to treat food allergy
by: Miguel Gonzalez-Visiedo, et al.
Published: (2022-09-01) -
Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
by: Christopher Chan, et al.
Published: (2023-10-01) -
A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR
by: Junping Zhang, et al.
Published: (2024-03-01) -
Editorial: Immunogenicity and toxicity of AAV gene therapy
by: Allison Bradbury, et al.
Published: (2023-06-01)